ROARABLE
FREE $100K
Today Screener Big Ideas Track Record πŸ’° $100K Arena 🎲 Predictions πŸ›οΈ Insiders 8 Analysts
Stock Ratings / Consumer Discretionary / OPRX / options
UXIN (29) DHX (51) AMWL (39) CURR (31) ⌘ Pro Terminal β†’

OptimizeRx Corporation (OPRX) Options Positioning, Max Pain & Unusual Sweeps

$9.41 +0.97% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.45

OptimizeRx Corporation (OPRX) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (67.3% gross margin, 7% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B- β€’ BUY Cap $175.6M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on OPRX Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is OPRX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, OptimizeRx Corporation (NASDAQ: OPRX) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $9.41 (+0.97% 1D, market cap $175.6M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 12/20, SEC Balance-Sheet Forensics 14/20, FRED Macro Regime Fit 16/20, and Executive Insider Alignment 15/20. Across 1009 tracked Consumer Discretionary issuers, OPRX ranks #143 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does OPRX compare to UXIN and DHX in the Consumer Discretionary sector?
β–Ό

Within the Consumer Discretionary sector (Business Services), OPRX carries a Roarable B- (71/100 RQD), trailing P/E of 34.4x, gross margin of 67.3%, and ROIC of 7.3%. By comparison, UXIN (Uxin Limited ADS) holds a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $195.8M) and DHX (DHI Group Inc.) posts a D grade (51/100 RQD, P/E N/A, ROIC -7.4%, cap $196.3M). Among the 5-stock peer group, OPRX leads on earnings multiple (34.4x) while OPRX leads on capital efficiency (7.3% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for OPRX?
β–Ό

Per OPRX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001448431), OptimizeRx Corporation generated $109.4M in revenue (+18.8% YoY), $5.1M in net income, and $18.7M in free cash flow against $176.9M in total assets and $21.4M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $9.45 (+0.41%)🧬 Cannibal Buyback (-2.08% YoY Shares)βš™οΈ Cash Engine: 14/20 (B-) β€’ 17% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 71/100 (B-) historically ranked in the Top 14% of excess returns over the next 90 days (+6.8% avg 90D alpha vs SPY β€’ 68.4% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERBUY β€’ B-
025507510071
3-of-3 JEV AI Jury Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C+ Β· Rk B
Cash (14)Whales (12)SEC (14)Macro (16)CEO (15)
Each axis scored 0–20
12M PRICE TARGET CONE+5.8% Base Target
$22 Bull$10 Base$8 Bear
πŸ“¬ FREE OPRX RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for OPRX)Realized 20D OHLCV Swing Band: Β±9.9%
Deterministic 5-Pillar Attribution (71/100 Composite)
πŸ” WHY OPRX SCORES 71/100 (B-) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Macro Regime Fit+16/20 pts (23% of score)

FRED Regime Γ— Technicals: 29% of 52W Range β€’ RSI-14 at 62.9 (BULLISH MOMENTUM)

β–² #2 Bullish Driver: Insider Conviction & Share Dilution+15/20 pts (21% of score)

SEC Form 4 / 13F Thermometer: 75% Net Buy β€’ Cannibal Buyback (-2.08% YoY Shares)

β–Ό #1 Drag / Risk Factor: Whale & Options Positioning12/20 pts (-8 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-8 pts vs max)

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
63
Grade C+$8.43+5.9% Next Q
Q2 (-2Q)
66
Grade B-$8.93+1.5% Next Q
Q3 (-1Q)
68
Grade B-$9.06+3.9% Next Q
Current
71
Grade B-$9.41+6.8% Hist 90D Ξ±
Trajectory: C+ (63) β†’ B- (71)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

βš”οΈ Adversarial Opposing Case: Why the OPRX Bull Thesis Could Fail

Gideon Ashmere Forensic Desk β†’

Even with a 71/100 (B-) score, OPRX faces multiple-compression risk if 34.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) β€” any gross margin slip below 64.8% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($8.27) or 200D SMA ($7.27) invalidates the momentum regime and cuts Target Base ($9.96) toward Bear Floor ($7.72).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $OPRXβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œOPRX Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 71%NO 29%Trade / Inspect Odds β†’
CALL VS. PUT WHALE SHARE
β€” (No Active Options Snapshot)
Put/Call Ratio: β€” (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
β€” (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
Β±9.9%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (OPRX)

β€” (No Active Options Snapshot) β€” No unusual CBOE strike concentration anomalies recorded in the current database snapshot for OPRX.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

πŸ† Enter Free $100K Paper Arena β†’
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating OPRX & AI Leaders Without Chasing Tops

  • βœ“Institutional whale strikes & implied earnings move audit on OPRX
  • βœ“How disciplined traders manage risk using pre-published trigger & invalidation levels
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) β†’$100K Arena
OPRX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +39.00%β–² ASCENDING CHANNEL
2026-11-03O $9.37H $9.41L $9.32C $9.41VOL 136.6K
RES: $9.93SUP: $8.41SMA50: $8.27SMA200: $7.27
$13.69$11.21$8.73$6.25$3.77RES $9.93SUP $8.41$9.412026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

OPRX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

πŸ¦‹ OPRX Butterfly Map β†’ + Track OPRX β†’
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
26.5%/yr Implied 5Y Growth

vs. +18.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on OPRX today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for OPRX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for OPRX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OPRX)

Consumer Discretionary Rank #143 of 1009 βš”οΈ UXIN vs OPRX Full Matrix β†’

1. Head-to-Head Consumer Discretionary Peer Comparison (OPRX vs. UXIN, DHX, AMWL, CURR)

Industry: Business Services (88 Tracked Issuers)

Across 1009 tracked Consumer Discretionary securities in the Roarable RQD universe, OptimizeRx Corporation (OPRX) ranks #143 by composite RQD confidence (71/100, grade B-) and #703 by equity capitalization ($175.6M). Within this direct 5-issuer industry benchmark cohort, OPRX leads on earnings valuation at 34.4x trailing P/E, while OPRX leads on capital efficiency and profitability with 7.3% ROIC and 67.3% gross margin. OPRX currently leads its immediate peer cohort in composite quantitative strength at 71/100 (B-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
OPRX ACTIVE
OptimizeRx Corporation
B- 71/100 34.4x 67.3% 7.3% +0.97% $175.6M Benchmark Subject
UXIN
Uxin Limited ADS
E 29/100 β€” 6.7% -35.0% +1.79% $195.8M /uxin-vs-oprx β†’
DHX
DHI Group Inc.
D 51/100 β€” 84.7% -7.4% +5.75% $196.3M /dhx-vs-oprx β†’
AMWL
American Well Corporation (Class A)
D- 39/100 β€” β€” -35.0% -1.65% $216.5M /amwl-vs-oprx β†’
CURR
Currenc Group Inc.
E 31/100 β€” 40.8% -35.0% -8.96% $238.0M /curr-vs-oprx β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001448431 β†—

In its most recent audited fiscal period (FY2025, filed 2025-12-31), OptimizeRx Corporation (OPRX) reported GAAP revenue of $109.4M (+18.8% vs. FY2024 revenue of $92.1M , and +53.0% cumulative change since FY2023) , GAAP net income of $5.1M, operating cash flow of $18.7M, and free cash flow of $18.7M (+290.6% YoY). On the balance sheet, OPRX closed FY2025 with $176.9M in total assets against $21.4M in total debt (Altman Z-Score: 2.68, Piotroski F-Score: 9/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $109.4M $5.1M $18.7M $18.7M $176.9M $21.4M
FY2024 (FY) 2024-12-31 $92.1M -$20.1M $4.9M $4.8M $171.2M $30.8M
FY2023 (FY) 2023-12-31 $71.5M -$17.6M -$7.2M -$7.2M β€” β€”

3. OPRX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is OPRX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, OptimizeRx Corporation (NASDAQ: OPRX) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $9.41 (+0.97% 1D, market cap $175.6M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 12/20, SEC Balance-Sheet Forensics 14/20, FRED Macro Regime Fit 16/20, and Executive Insider Alignment 15/20. Across 1009 tracked Consumer Discretionary issuers, OPRX ranks #143 in composite RQD confidence.

How does OPRX compare to UXIN and DHX in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Business Services), OPRX carries a Roarable B- (71/100 RQD), trailing P/E of 34.4x, gross margin of 67.3%, and ROIC of 7.3%. By comparison, UXIN (Uxin Limited ADS) holds a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $195.8M) and DHX (DHI Group Inc.) posts a D grade (51/100 RQD, P/E N/A, ROIC -7.4%, cap $196.3M). Among the 5-stock peer group, OPRX leads on earnings multiple (34.4x) while OPRX leads on capital efficiency (7.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for OPRX?

Per OPRX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001448431), OptimizeRx Corporation generated $109.4M in revenue (+18.8% YoY), $5.1M in net income, and $18.7M in free cash flow against $176.9M in total assets and $21.4M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

Where is OPRX trading relative to its 50-day, 200-day, and 52-week technical levels?

OPRX last traded at $9.41 (+0.97% on volume of 148,290 shares), positioning the stock +13.78% above its 50-day simple moving average ($8.27) and +29.44% above its 200-day simple moving average ($7.27). Across its 52-week range of $4.54 to $21.09, OPRX sits at the 29.4% percentile with a 14-day RSI of 62.9 (BULLISH MOMENTUM) and an implied next-earnings move of Β±9.9% ($8.48 to $10.34).

Direct Sub-Reports: OPRX RQD Cockpit OPRX 12M Forecast OPRX Earnings & Move OPRX Dividends & DRIP OPRX Insiders & 13F OPRX Whale Options OPRX Profit Sankey OPRX News & Why
ROARABLE RATING BRIEF β€’ RQD 71/100 (B-) βœ“ SEC XBRL & RQD VERIFIED

OPRX β€” OptimizeRx Corporation: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

OptimizeRx Corporation (OPRX) earns a live Roarable RQD composite score of 71/100, corresponding to a B- letter grade (Roarable Buy) at a spot price of $9.41 (+0.97% 1D, market capitalization $175.6M).

  • Fundamental Cash Engine (14/20): Anchored by return on invested capital (ROIC) of 7.3%, gross margin of 67.3%, operating margin of 10.7%, and free cash flow yield of 10.57%.
  • Whale 13F & Options Flow (12/20) + Insider Conviction (15/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (16/20) + Forensic Balance Sheet (14/20): Incorporates a 1.00x equity beta, Altman Z-Score of 2.68, Piotroski F-Score of 9/9, and Debt/Equity of 0.17x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Sector is Consumer Discretionary and industry is Business Services, listed on NASDAQ. The profile section does not describe the company's products, customers, or revenue model. Gross margin is 67.3%, operating margin is 10.7%, and net margin is 4.7%.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), OptimizeRx Corporation (OPRX) reported $109.4M in annual revenue (up from $92.1M in FY2024, +18.8% YoY) and $5.1M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($71.5M revenue, -$17.6M net income) through FY2025, OPRX scaled operating cash flow to $18.7M and free cash flow to $18.7M, backed by $176.9M in total assets against $21.4M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • πŸ‚ Primary Bull Case (B- β€’ RQD 71/100): Company leadership has skin in the game with net positive insider conviction. Free cash flow yield of 10.57% and institutional whale pillar of 12/20. With Fundamental Cash Engine at 14/20 and Institutional Whale Flow at 12/20, sustained execution supports upside toward the upper end of the $4.54 – $21.09 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 34.4x trailing P/E and 14.9x EV/EBITDA against 10.7% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Business Services (Consumer Discretionary), OPRX carries a macro regime beta of 1.00 and gross margin of 67.3%.

  • Key Question #1: Can OPRX sustain or expand its 10.7% operating margin and 7.3% ROIC against Business Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $109.4M and free cash flow of $18.7M, how will capital allocation balance growth reinvestment against $21.4M in total debt?
  • Key Question #3: How sensitive is OPRX's 28.9x forward P/E multiple to Consumer Discretionary capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

OPRX Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for OptimizeRx Corporation (OPRX) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to OPRX Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

OPRX Bull vs. Bear Conversation Board β€” What's Your Call at $9.41?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON OPRX 🐻 33% BEARISH CONVICTION
1. Pick Your Side on OPRX:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MI MidwestValue RQD DEBATE OPENER β€’ Fundamental Long-Only πŸ‚ BULLISH 🎯 Target: $11.65 (+25.0%)
πŸ“Œ Pinned Debate

Revenue rose from $71.5M in FY 2023 to $109.4M in FY 2025 while operating income turned positive at $11.7M, supported by a 10.57% FCF y

Don't sleep on OPRX's setup in Consumer Discretionary. Revenue rose from $71.5M in FY 2023 to $109.4M in FY 2025 while operating income turned positive at $11.7M, supported by a 10.57% FCF yield and a Piotroski F-Score of 9/9.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (71/100) backs up the fundamental quality.

RetailWhale_TX πŸ‚ BULL

@MeanReversion_88 Shorting a 12/20 institutional whale-flow stock at $9.32 is dangerous when funds are rotating into Consumer Discretionary.

ME MeanReversion_88 RQD DEBATE OPENER β€’ Quantitative Statistical Arb 🐻 BEARISH 🎯 Target: $7.83 (-16.0%)
Spot @ $9.32

The stock trades at a P/E (TTM) of 34.4 and EV/EBITDA of 14.9 on EPS (TTM) of 0.27, with an Altman Z-Score of 2.68 and ROIC of only 7.3

Sitting on the sidelines or leaning short OPRX above $9.32. The stock trades at a P/E (TTM) of 34.4 and EV/EBITDA of 14.9 on EPS (TTM) of 0.27, with an Altman Z-Score of 2.68 and ROIC of only 7.3%.. Until Fundamental Cash Engine (14/20) and FCF yield (10.57%) inflect higher, upside is capped near $21.09.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%